OTCMKTS:ERGO Entia Biosciences Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Entia Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.02 0.00 (0.00 %) (As of 09/29/2020 12:00 AM ET) Add Compare Share Today's Range$0.02Now: $0.02▼$0.0250-Day Range$0.01MA: $0.01▼$0.0252-Week Range$0.01Now: $0.02▼$0.04VolumeN/AAverage Volume26,100 shsMarket Capitalization$510,900.00P/E RatioN/ADividend YieldN/ABeta1.85 ProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestSocial Media Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Entia Biosciences. Previous Next 2.3 Community Rank Outperform VotesEntia Biosciences has received 72 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEntia Biosciences has received 84 “underperform” votes. (Add your “underperform” vote.)Community SentimentEntia Biosciences has received 53.85% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Entia Biosciences and other stocks. Vote “Outperform” if you believe ERGO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ERGO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEntia Biosciences does not currently pay a dividend.Dividend GrowthEntia Biosciences does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Entia Biosciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 28.30% of the stock of Entia Biosciences is held by insiders. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ERGO Previous Symbol CUSIPN/A CIK1408299 Webwww.entiabio.com Phone971-228-0709Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees6 Outstanding Shares34,060,000Market Cap$510,900.00 Next Earnings DateN/A OptionableNot Optionable $0.02 0.00 (0.00 %) (As of 09/29/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ERGO News and Ratings via Email Sign-up to receive the latest news and ratings for ERGO and its competitors with MarketBeat's FREE daily newsletter. Entia Biosciences (OTCMKTS:ERGO) Frequently Asked Questions How has Entia Biosciences' stock price been impacted by COVID-19 (Coronavirus)? Entia Biosciences' stock was trading at $0.0065 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ERGO shares have increased by 130.8% and is now trading at $0.0150. View which stocks have been most impacted by COVID-19. Who are some of Entia Biosciences' key competitors? Some companies that are related to Entia Biosciences include Actelion (ALIOF), STADA Arzneimittel (STDAF), Canopy Growth (CGC), Cronos Group (CRON), USANA Health Sciences (USNA), Aphria (APHA), Aphria (APHA), Tilray (TLRY), Aurora Cannabis (ACB), Canopy Rivers (RIV), Chromadex (CDXC), Mediwound (MDWD), Charlie's (CHUC), Natural Alternatives International (NAII) and Happiness Biotech Group (HAPP). View all competitors. What other stocks do shareholders of Entia Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Entia Biosciences investors own include Woodward, Inc.Common Stock (WWD), Drone Delivery Canada (TAKOF), Centrica (CNA) and Aurora Cannabis (ACB). Who are Entia Biosciences' key executives? Entia Biosciences' management team includes the following people: Dr. Marvin S. Hausman M.D., Chairman and Chief Science & Technology Officer (Age 78)Mr. Timothy A. Timmins, CEO & Pres (Age 62)Mr. Elliot A. L. Shelton Esq., Sec. and Director (Age 69)William Meyer, Head of Production What is Entia Biosciences' stock symbol? Entia Biosciences trades on the OTCMKTS under the ticker symbol "ERGO." How do I buy shares of Entia Biosciences? Shares of ERGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Entia Biosciences' stock price today? One share of ERGO stock can currently be purchased for approximately $0.02. How big of a company is Entia Biosciences? Entia Biosciences has a market capitalization of $510,900.00. Entia Biosciences employs 6 workers across the globe. What is Entia Biosciences' official website? The official website for Entia Biosciences is www.entiabio.com. How can I contact Entia Biosciences? Entia Biosciences' mailing address is 13565 SW TUALATIN-SHERWOOD ROAD. SUITE 800, SHERWOOD OR, 97140. The biotechnology company can be reached via phone at 971-228-0709. This page was last updated on 9/30/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
